Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan L Schultz

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Pharmacotherapy|February 19, 2016
Implementation and Clinical Outcomes of an Employer-Sponsored, Pharmacist-Provided Medication Therapy Management Program--Alternative ViewpointJordan L Schultz
Neurology|February 27, 2019
Author response: Evaluating depression and suicidality in tetrabenazine users with Huntington diseaseJordan L Schultz
Neurology|April 22, 2025
Juvenile Huntington Disease: Timing Is EverythingJordan L Schultz, Peg Nopoulos
Neurology|November 25, 2025
Juvenile Huntington Disease: Timing Is EverythingJordan L Schultz, Peg Nopoulos
Movement Disorders Clinical Practice|July 21, 2023
Memantine Use and Cognitive Decline in Huntington's Disease: An Enroll-HD StudyAmy C Ogilvie, Jordan L Schultz
Brain Sciences|August 30, 2020
Autonomic Changes in Juvenile-Onset Huntington's DiseaseJordan L Schultz, Peg C Nopoulos
Journal of Huntington'S Disease|November 5, 2025
Early life functional advantage coupled with accelerated aging: The case for antagonistic pleiotropy in Huntington's diseaseJordan L Schultz, Peg C Nopoulos
Brain : a Journal of Neurology|October 10, 2023
Unravelling the role of huntingtin: from neurodevelopment to neurodegenerationJordan L Schultz, Mohit Neema, Peg C Nopoulos
Neurology|March 11, 2021
Association of CAG Repeat Length in the Huntington Gene With Cognitive Performance in Young AdultsJordan L Schultz, Carsten Saft, Peggy C Nopoulos
Movement Disorders : Official Journal of the Movement Disorder Society|December 28, 2020
Diabetes Mellitus Is Associated With an Earlier Age of Onset of Huntington's DiseaseAmy C Ogilvie, Pedro Gonzalez-Alegre, Jordan L Schultz
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Pharmacotherapy|February 19, 2016
Implementation and Clinical Outcomes of an Employer-Sponsored, Pharmacist-Provided Medication Therapy Management Program--Alternative ViewpointJordan L Schultz
Neurology|February 27, 2019
Author response: Evaluating depression and suicidality in tetrabenazine users with Huntington diseaseJordan L Schultz
Neurology|April 22, 2025
Juvenile Huntington Disease: Timing Is EverythingJordan L Schultz, Peg Nopoulos
Neurology|November 25, 2025
Juvenile Huntington Disease: Timing Is EverythingJordan L Schultz, Peg Nopoulos
Movement Disorders Clinical Practice|July 21, 2023
Memantine Use and Cognitive Decline in Huntington's Disease: An Enroll-HD StudyAmy C Ogilvie, Jordan L Schultz
Brain Sciences|August 30, 2020
Autonomic Changes in Juvenile-Onset Huntington's DiseaseJordan L Schultz, Peg C Nopoulos
Journal of Huntington'S Disease|November 5, 2025
Early life functional advantage coupled with accelerated aging: The case for antagonistic pleiotropy in Huntington's diseaseJordan L Schultz, Peg C Nopoulos
Brain : a Journal of Neurology|October 10, 2023
Unravelling the role of huntingtin: from neurodevelopment to neurodegenerationJordan L Schultz, Mohit Neema, Peg C Nopoulos
Neurology|March 11, 2021
Association of CAG Repeat Length in the Huntington Gene With Cognitive Performance in Young AdultsJordan L Schultz, Carsten Saft, Peggy C Nopoulos
Movement Disorders : Official Journal of the Movement Disorder Society|December 28, 2020
Diabetes Mellitus Is Associated With an Earlier Age of Onset of Huntington's DiseaseAmy C Ogilvie, Pedro Gonzalez-Alegre, Jordan L Schultz
Pageof 6